REVBW
Closed
Revelation Biosciences Inc
0.0139
+0.0019 (+15.83%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.012
Day's Range: 0.0102 - 0.0139
Send
sign up or login to leave a comment!
When Written:
0.0199
Revelation Biosciences Inc is a biotechnology company that specializes in the discovery and development of therapeutics for neurodegenerative diseases. The company was founded in 2017 and is headquartered in Pasadena, California.
Revelation Biosciences is focused on developing small molecule therapeutics that target the underlying causes of neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's disease. The company's lead drug candidate, RVL-1201, is a novel small molecule that targets the toxic protein aggregates that are associated with these diseases.
The company has also developed a proprietary drug discovery platform called the M-Track platform, which uses a combination of computational and experimental approaches to identify and optimize drug candidates for neurodegenerative diseases.
Revelation Biosciences has received funding from a number of sources, including the National Institutes of Health and private investors. The company is led by a team of experienced biotech executives and scientists with a track record of success in drug discovery and development.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Revelation Biosciences is focused on developing small molecule therapeutics that target the underlying causes of neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's disease. The company's lead drug candidate, RVL-1201, is a novel small molecule that targets the toxic protein aggregates that are associated with these diseases.
The company has also developed a proprietary drug discovery platform called the M-Track platform, which uses a combination of computational and experimental approaches to identify and optimize drug candidates for neurodegenerative diseases.
Revelation Biosciences has received funding from a number of sources, including the National Institutes of Health and private investors. The company is led by a team of experienced biotech executives and scientists with a track record of success in drug discovery and development.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!